Crohn's and colitis drug effective in trials

Two studies published this week in the New England Journal of Medicine could bring relief to people suffering from Crohn's disease and ulcerative colitis. They report two international phase 3 clinical trials called GEMINI I and GEMINI II that found the investigational drug vedolizumab is an effective treatment for patients with the inflammatory bowel conditions for whom other treatments have not worked...
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Crohn's / IBD Source Type: news